BridgeBio Pharma’s License Agreement with Bristol Myers Squibb

Martina Bellini North America Legal Chronicle
Tagged:

Goodwin Procter advised BridgeBio Pharma, Inc. on the deal.BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced its exclusive license agreement wit Bristol Myers Squibb to develop and commercialize…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here